# Bioequivalence Study of Fentanyl Transdermal System (JNJ-35685-AAA-G021) Compared With DURAGESIC Fentanyl Transdermal Patch in Healthy Participants

> **NCT02617758** · PHASE1 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 56 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Fentanyl
- **DRUG:** Fentanyl

## Key facts

- **NCT ID:** NCT02617758
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2025-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02617758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02617758, "Bioequivalence Study of Fentanyl Transdermal System (JNJ-35685-AAA-G021) Compared With DURAGESIC Fentanyl Transdermal Patch in Healthy Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02617758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*